Stomach Cancer ED

  • A blood-based test for diagnosis of gastric cancer by detecting a combination of proprietary epigenomics DNA methylation biomarkers.

0 People watching this product now!
  • Sensitivity 80.77%
  • Specificity 92.07%
  • A blood-based test for diagnosis of gastric cancer by detecting a combination of proprietary epigenomics DNA methylation biomarkers.
  • Detection of early gastric cancer & precancerous lesions.
  • Patients with a positive test result should be referred for diagnostic
  • Patients with a negative test result should discuss with their doctor when they need to be tested again.
  • Follow-up and monitoring.
  • Prognostic evaluation.
  • Therapeutic assessment.
  • Tumor markers, like CEA and CA-199, low sensitivity.
  • Gastroscope, invasive with low follow-up rate.
  • PG and G17, low specificity.
  • Male & female aged 40 and above.
  • A history of gastric cancer in first degree relatives.
  • Been diagnosed with other gastric precancerous disease(s), like chronic atrophic gastritis (CAG), gastric ulcer, gastric polyps, residual stomach, hypertrophic gastritis, or pernicious anemia.
  • Helicobacter pylori infection
  • Areas with a high incidence of gastric cancer, other risk factors of gastric cancer (eg.high salt intake, pickled diet, smoking, drinking).

Related Products

Recently Viewed Products